NPM1 and chronic myelomonocytic leukemia: In general, the prognosis is poor in advanced CMML, RAS‐driven CMML, NPM1‐mutated CMML (recognized by ICC), and drug‐resistant CMML [62, 63, 64, 65, 66, 67, 68].